JP2017535612A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017535612A5 JP2017535612A5 JP2017545857A JP2017545857A JP2017535612A5 JP 2017535612 A5 JP2017535612 A5 JP 2017535612A5 JP 2017545857 A JP2017545857 A JP 2017545857A JP 2017545857 A JP2017545857 A JP 2017545857A JP 2017535612 A5 JP2017535612 A5 JP 2017535612A5
- Authority
- JP
- Japan
- Prior art keywords
- nasal
- disorder
- preparation
- riluzole
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- FTALBRSUTCGOEG-UHFFFAOYSA-N Riluzole Chemical compound C1=C(OC(F)(F)F)C=C2SC(N)=NC2=C1 FTALBRSUTCGOEG-UHFFFAOYSA-N 0.000 claims 7
- 229960004181 riluzole Drugs 0.000 claims 7
- 208000019901 Anxiety disease Diseases 0.000 claims 4
- 230000036506 anxiety Effects 0.000 claims 4
- 208000010877 cognitive disease Diseases 0.000 claims 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 3
- 208000024827 Alzheimer disease Diseases 0.000 claims 2
- 206010013142 Disinhibition Diseases 0.000 claims 2
- 201000011240 Frontotemporal dementia Diseases 0.000 claims 2
- 206010022998 Irritability Diseases 0.000 claims 2
- 208000035475 disorder Diseases 0.000 claims 2
- 230000000694 effects Effects 0.000 claims 2
- 230000002996 emotional effect Effects 0.000 claims 2
- 238000009472 formulation Methods 0.000 claims 2
- 208000027061 mild cognitive impairment Diseases 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 229940002612 prodrug Drugs 0.000 claims 2
- 239000000651 prodrug Substances 0.000 claims 2
- 230000001225 therapeutic effect Effects 0.000 claims 2
- 208000004998 Abdominal Pain Diseases 0.000 claims 1
- 206010000060 Abdominal distension Diseases 0.000 claims 1
- 206010001497 Agitation Diseases 0.000 claims 1
- 208000000044 Amnesia Diseases 0.000 claims 1
- 206010003591 Ataxia Diseases 0.000 claims 1
- 208000006096 Attention Deficit Disorder with Hyperactivity Diseases 0.000 claims 1
- 208000036864 Attention deficit/hyperactivity disease Diseases 0.000 claims 1
- 208000020925 Bipolar disease Diseases 0.000 claims 1
- 208000028698 Cognitive impairment Diseases 0.000 claims 1
- 206010010219 Compulsions Diseases 0.000 claims 1
- 206010012218 Delirium Diseases 0.000 claims 1
- 206010012289 Dementia Diseases 0.000 claims 1
- 206010012735 Diarrhoea Diseases 0.000 claims 1
- 208000000059 Dyspnea Diseases 0.000 claims 1
- 206010013975 Dyspnoeas Diseases 0.000 claims 1
- 208000030814 Eating disease Diseases 0.000 claims 1
- 208000019454 Feeding and Eating disease Diseases 0.000 claims 1
- 208000002339 Frontotemporal Lobar Degeneration Diseases 0.000 claims 1
- 208000023105 Huntington disease Diseases 0.000 claims 1
- 208000008454 Hyperhidrosis Diseases 0.000 claims 1
- 208000020358 Learning disease Diseases 0.000 claims 1
- 206010026749 Mania Diseases 0.000 claims 1
- 208000026139 Memory disease Diseases 0.000 claims 1
- 208000036626 Mental retardation Diseases 0.000 claims 1
- 208000019022 Mood disease Diseases 0.000 claims 1
- 206010028813 Nausea Diseases 0.000 claims 1
- 206010060860 Neurological symptom Diseases 0.000 claims 1
- 208000008589 Obesity Diseases 0.000 claims 1
- 206010029897 Obsessive thoughts Diseases 0.000 claims 1
- 208000021384 Obsessive-Compulsive disease Diseases 0.000 claims 1
- 206010033557 Palpitations Diseases 0.000 claims 1
- 208000018737 Parkinson disease Diseases 0.000 claims 1
- 206010034568 Peripheral coldness Diseases 0.000 claims 1
- 206010034912 Phobia Diseases 0.000 claims 1
- 206010036790 Productive cough Diseases 0.000 claims 1
- 206010037180 Psychiatric symptoms Diseases 0.000 claims 1
- 208000028017 Psychotic disease Diseases 0.000 claims 1
- 208000006289 Rett Syndrome Diseases 0.000 claims 1
- 206010039897 Sedation Diseases 0.000 claims 1
- 206010041250 Social phobia Diseases 0.000 claims 1
- 208000027520 Somatoform disease Diseases 0.000 claims 1
- 208000009415 Spinocerebellar Ataxias Diseases 0.000 claims 1
- 208000010112 Spinocerebellar Degenerations Diseases 0.000 claims 1
- 206010048327 Supranuclear palsy Diseases 0.000 claims 1
- 208000009205 Tinnitus Diseases 0.000 claims 1
- 210000001015 abdomen Anatomy 0.000 claims 1
- 206010000059 abdominal discomfort Diseases 0.000 claims 1
- 230000016571 aggressive behavior Effects 0.000 claims 1
- 238000013019 agitation Methods 0.000 claims 1
- 206010002026 amyotrophic lateral sclerosis Diseases 0.000 claims 1
- 208000015802 attention deficit-hyperactivity disease Diseases 0.000 claims 1
- 231100000870 cognitive problem Toxicity 0.000 claims 1
- 230000007423 decrease Effects 0.000 claims 1
- 230000013872 defecation Effects 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 235000014632 disordered eating Nutrition 0.000 claims 1
- 208000002173 dizziness Diseases 0.000 claims 1
- 206010013663 drug dependence Diseases 0.000 claims 1
- 206010013781 dry mouth Diseases 0.000 claims 1
- 230000004064 dysfunction Effects 0.000 claims 1
- 208000027700 hepatic dysfunction Diseases 0.000 claims 1
- 201000003636 hereditary ataxia Diseases 0.000 claims 1
- 208000035231 inattentive type attention deficit hyperactivity disease Diseases 0.000 claims 1
- 208000002551 irritable bowel syndrome Diseases 0.000 claims 1
- 201000003723 learning disability Diseases 0.000 claims 1
- 208000019423 liver disease Diseases 0.000 claims 1
- 230000005976 liver dysfunction Effects 0.000 claims 1
- 230000006984 memory degeneration Effects 0.000 claims 1
- 208000023060 memory loss Diseases 0.000 claims 1
- 230000036651 mood Effects 0.000 claims 1
- 210000003205 muscle Anatomy 0.000 claims 1
- 230000008693 nausea Effects 0.000 claims 1
- 208000015122 neurodegenerative disease Diseases 0.000 claims 1
- 231100000862 numbness Toxicity 0.000 claims 1
- 239000007935 oral tablet Substances 0.000 claims 1
- 229940096978 oral tablet Drugs 0.000 claims 1
- 208000027753 pain disease Diseases 0.000 claims 1
- 208000022821 personality disease Diseases 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 208000019899 phobic disease Diseases 0.000 claims 1
- 208000028173 post-traumatic stress disease Diseases 0.000 claims 1
- 230000003989 repetitive behavior Effects 0.000 claims 1
- 208000013406 repetitive behavior Diseases 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 208000013220 shortness of breath Diseases 0.000 claims 1
- 208000019116 sleep disease Diseases 0.000 claims 1
- 239000012453 solvate Substances 0.000 claims 1
- 208000024794 sputum Diseases 0.000 claims 1
- 210000003802 sputum Anatomy 0.000 claims 1
- 208000011117 substance-related disease Diseases 0.000 claims 1
- 231100000886 tinnitus Toxicity 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462083068P | 2014-11-21 | 2014-11-21 | |
| US62/083,068 | 2014-11-21 | ||
| PCT/US2015/061106 WO2016081466A1 (en) | 2014-11-21 | 2015-11-17 | Sublingual administration of riluzole |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017535612A JP2017535612A (ja) | 2017-11-30 |
| JP2017535612A5 true JP2017535612A5 (enExample) | 2018-11-01 |
Family
ID=55077617
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017545857A Pending JP2017535612A (ja) | 2014-11-21 | 2015-11-17 | リルゾールの舌下投与 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20180153862A1 (enExample) |
| EP (1) | EP3220890A1 (enExample) |
| JP (1) | JP2017535612A (enExample) |
| KR (1) | KR20170137030A (enExample) |
| CN (1) | CN107735077A (enExample) |
| AU (1) | AU2015350142A1 (enExample) |
| BR (1) | BR112017010440A2 (enExample) |
| CA (1) | CA2967659A1 (enExample) |
| EA (1) | EA201791110A1 (enExample) |
| IL (1) | IL252283A0 (enExample) |
| MX (1) | MX2017006454A (enExample) |
| PH (1) | PH12017500933A1 (enExample) |
| SG (1) | SG11201703897SA (enExample) |
| WO (1) | WO2016081466A1 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9925282B2 (en) | 2009-01-29 | 2018-03-27 | The General Hospital Corporation | Cromolyn derivatives and related methods of imaging and treatment |
| HK1223541A1 (zh) | 2013-10-22 | 2017-08-04 | The General Hospital Corporation | 色甘酸衍生物以及成像和治疗的相关方法 |
| SI3220891T1 (sl) | 2014-11-21 | 2020-02-28 | Biohaven Therapeutics Ltd. | Podjezična formulacija riluzola |
| US9899038B2 (en) | 2016-06-30 | 2018-02-20 | Karen Elaine Khaleghi | Electronic notebook system |
| EP3506894B1 (en) | 2016-08-31 | 2023-08-23 | The General Hospital Corporation | Macrophages/microglia in neuro-inflammation associated with neurodegenerative diseases |
| RU2021101120A (ru) * | 2016-09-15 | 2022-03-16 | Скинтек Лайф Сайенс Лимитед | Сублингвальное или буккальное введение dim для лечения заболеваний кожи |
| RU2020130837A (ru) | 2018-02-21 | 2022-03-21 | ЭйАй ТЕРАПЬЮТИКС, ИНК. | Комбинационная терапия апилимодом и глутаматергическими агентами |
| US10235998B1 (en) * | 2018-02-28 | 2019-03-19 | Karen Elaine Khaleghi | Health monitoring system and appliance |
| CA3096545A1 (en) * | 2018-04-09 | 2019-10-17 | The General Hospital Corporation | Combination therapies for the treatment of amyotropic lateral sclerosis and related disorders |
| CA3101597A1 (en) * | 2018-05-27 | 2019-12-05 | Biohaven Pharmaceutical Holding Company Ltd. | Use of riluzole oral disintigrating tablets for treating diseases |
| ES2987802T3 (es) * | 2018-08-16 | 2024-11-18 | Biohaven Therapeutics Ltd | Uso de comprimidos bucodispersables de riluzol para el tratamiento de enfermedades |
| AU2019397436A1 (en) | 2018-12-10 | 2021-07-22 | The General Hospital Corporation | Cromolyn esters and uses thereof |
| US10559307B1 (en) | 2019-02-13 | 2020-02-11 | Karen Elaine Khaleghi | Impaired operator detection and interlock apparatus |
| EP4132507A4 (en) | 2020-04-06 | 2024-05-15 | The General Hospital Corporation | METHODS FOR TREATING CORONAVIRUS-INDUCED INFLAMMATORY CONDITIONS |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2492258A1 (fr) * | 1980-10-17 | 1982-04-23 | Pharmindustrie | Nouveau medicament a base d'amino-2 trifluoromethoxy-6 benzothiazole |
| US5837287A (en) * | 1994-10-28 | 1998-11-17 | R P Scherer Corporation | Process for preparing solid pharmaceutical dosage forms |
| FR2787028B1 (fr) * | 1998-12-15 | 2002-10-18 | Aventis Pharma Sa | Utilisation du riluzole dans le traitement des traumatismes acoustiques |
| ATE419851T1 (de) * | 1999-06-04 | 2009-01-15 | Vereniging Voor Christelijk Wetenschappelijk Onderwijs | Verwendung von riluzol zur behandlung multipler sklerose |
| US20040077591A1 (en) * | 2002-03-28 | 2004-04-22 | The Brigham And Women's Hospital, Inc. | Histone deacetylase inhibitors for the treatment of multiple sclerosis, amyotrophic lateral sclerosis and Alzheimer's Disease |
| GB0304636D0 (en) * | 2003-02-28 | 2003-04-02 | Britannia Pharmaceuticals Ltd | Pharmaceutical composition for nasal delivery |
| EP2228054A1 (en) * | 2009-03-13 | 2010-09-15 | ITALFARMACO S.p.A. | Riluzole aqueous suspensions |
| JP2011093849A (ja) * | 2009-10-30 | 2011-05-12 | Kissei Pharmaceutical Co Ltd | トラニラストの易溶性粉末吸入製剤 |
| US9241933B2 (en) * | 2011-03-01 | 2016-01-26 | Pharnext | Compositions for treating amyotrophic lateral sclerosis |
| HK1197178A1 (en) * | 2011-07-13 | 2015-01-09 | Cytokinetics, Inc. | Combination als therapy |
| IN2014DN07989A (enExample) * | 2012-03-01 | 2015-05-01 | Pharnext |
-
2015
- 2015-11-17 JP JP2017545857A patent/JP2017535612A/ja active Pending
- 2015-11-17 EA EA201791110A patent/EA201791110A1/ru unknown
- 2015-11-17 EP EP15821185.4A patent/EP3220890A1/en not_active Withdrawn
- 2015-11-17 CN CN201580073646.5A patent/CN107735077A/zh active Pending
- 2015-11-17 MX MX2017006454A patent/MX2017006454A/es unknown
- 2015-11-17 BR BR112017010440A patent/BR112017010440A2/pt not_active Application Discontinuation
- 2015-11-17 KR KR1020177016605A patent/KR20170137030A/ko not_active Withdrawn
- 2015-11-17 SG SG11201703897SA patent/SG11201703897SA/en unknown
- 2015-11-17 CA CA2967659A patent/CA2967659A1/en not_active Abandoned
- 2015-11-17 US US15/100,162 patent/US20180153862A1/en not_active Abandoned
- 2015-11-17 WO PCT/US2015/061106 patent/WO2016081466A1/en not_active Ceased
- 2015-11-17 AU AU2015350142A patent/AU2015350142A1/en not_active Abandoned
-
2017
- 2017-05-15 IL IL252283A patent/IL252283A0/en unknown
- 2017-05-19 PH PH12017500933A patent/PH12017500933A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017535612A5 (enExample) | ||
| JP2017535613A5 (enExample) | ||
| Jee et al. | Impact of sleep disorder as a risk factor for dementia in men and women | |
| Mischoulon et al. | Role of S-adenosyl-L-methionine in the treatment of depression: a review of the evidence | |
| IL191311A (en) | Transdermal therapeutic system and its use in the preparation of drugs for the prevention, treatment or delay of the progression of Alzheimer's disease, Parkinson's disease-related dementia and symptoms of traumatic brain injury | |
| RU2013154699A (ru) | Сцилло-инозитол для применения в лечении поведенческих и психических расстройств | |
| Laura et al. | The effects of music therapy on anxiety and depression | |
| Almikhlafi | The role of exercise in Parkinson’s Disease | |
| JP2017526693A5 (enExample) | ||
| Winkelman et al. | Current patterns and future directions in the treatment of insomnia | |
| JP2016505050A5 (enExample) | ||
| CN104127730A (zh) | 一种治疗神经衰弱的中药及其制备方法 | |
| Shinde et al. | Homoeopathy for post COVID 19 illnesses: A case series | |
| Im et al. | Management of sleep disorders in stroke | |
| CN104606636A (zh) | 一种治疗抑郁症的中药组合物及其制备方法 | |
| Jung et al. | The Effect of Laughter Therapy on Sleep in the Community-dwelling Elderly. | |
| CN103656380A (zh) | 一种治疗帕金森病的药物 | |
| CN105079350A (zh) | 治疗失眠症的中药组合物 | |
| CN208211856U (zh) | 连体颈舒枕 | |
| CN110680880A (zh) | 一种治疗肝阳上亢型失眠的中药组合物及其用途 | |
| CN106177761B (zh) | 一种抗抑郁的中药组方及其制品 | |
| JP2017511386A5 (enExample) | ||
| D’yakonov et al. | Comparative studies of the efficacy of combinations of SSRI antidepressants and antipsychotics in the treatment of recurrent depressive disorder | |
| Hajilou | Review of Different Applications of Sildenafil with the Focus on its Role in Alzheimer's Disease | |
| Kalko et al. | Potential risks and pharmacological safety features of hypnotics. Music therapy as a non-drug way to improve sleep quality |